EA201190093A1 - Способ изготовления солей розувастатина - Google Patents
Способ изготовления солей розувастатинаInfo
- Publication number
- EA201190093A1 EA201190093A1 EA201190093A EA201190093A EA201190093A1 EA 201190093 A1 EA201190093 A1 EA 201190093A1 EA 201190093 A EA201190093 A EA 201190093A EA 201190093 A EA201190093 A EA 201190093A EA 201190093 A1 EA201190093 A1 EA 201190093A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- water
- rosuvastatin
- zinc ions
- calcium
- salts
- Prior art date
Links
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical class CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- -1 methanesulfonyl-methyl-amino Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 abstract 1
- 229960000672 rosuvastatin Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical class CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к новому способу приготовления солей розувастатина [7-[4-(4-фторфенил)-6-изопропил-2-(метансульфонил-метил-амино)пиримидин-5-ил]-(3R,5S)-дигидрокси-гепт-6-еноевой кислоты] формулы (I), образованных при помощи бивалентных катионов, предпочтительно при помощи ионов кальция или цинка, характеризующемуся тем, что проводят реакцию трет-бутиламмониевой соли розувастатина с соответствующим бивалентным катионом, предпочтительно ионами кальция или цинка, в смеси не смешивающегося или слабо смешивающегося с водой органического растворителя и воды, и образованную соль выделяют.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900019A HU0900019D0 (en) | 2009-01-15 | 2009-01-15 | Process for producing rosuvastatin |
HU0900460A HU230848B1 (en) | 2009-07-24 | 2009-07-24 | Process for producing rosuvastatin salts |
PCT/HU2010/000007 WO2010082072A1 (en) | 2009-01-15 | 2010-01-15 | Process for the preparation of rosuvastatin salts |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201190093A1 true EA201190093A1 (ru) | 2012-02-28 |
EA021942B1 EA021942B1 (ru) | 2015-10-30 |
Family
ID=89989132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201190093A EA021942B1 (ru) | 2009-01-15 | 2010-01-15 | Способ изготовления солей розувастатина |
Country Status (10)
Country | Link |
---|---|
US (1) | US8507513B2 (ru) |
EP (1) | EP2389365A1 (ru) |
CN (1) | CN102317267A (ru) |
AU (1) | AU2010205464A1 (ru) |
BR (1) | BRPI1005147A2 (ru) |
CA (1) | CA2749727A1 (ru) |
EA (1) | EA021942B1 (ru) |
MX (1) | MX2011007478A (ru) |
WO (1) | WO2010082072A1 (ru) |
ZA (1) | ZA201105124B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU227696B1 (en) * | 2006-04-13 | 2011-12-28 | Egyt Gyogyszervegyeszeti Gyar | Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it |
UA103544C2 (ru) * | 2009-07-24 | 2013-10-25 | Егіш Дьйодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг | Кристаллическая форма i цинковой соли розувастатина |
HU230737B1 (hu) * | 2010-11-16 | 2018-01-29 | EGIS Gyógyszergyár Nyrt | Eljárás rosuvastatin só előállítására |
HU230987B1 (hu) * | 2010-11-29 | 2019-08-28 | Egis Gyógyszergyár Nyrt. | Eljárás nagy tisztaságú gyógyszeripari intermedierek előállítására |
HU229260B1 (en) | 2010-11-29 | 2013-10-28 | Egis Gyogyszergyar Nyrt | Process for preparation of rosuvastatin salts |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
EA200401533A1 (ru) | 2002-05-21 | 2005-06-30 | Ранбакси Лабораторис Лимитед | Способ получения росувастатина |
GB0218781D0 (en) * | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
WO2005023778A2 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
UY28501A1 (es) * | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
GB0321827D0 (en) * | 2003-09-18 | 2003-10-15 | Astrazeneca Uk Ltd | Chemical compounds |
EP1678148A1 (en) | 2003-10-22 | 2006-07-12 | Ranbaxy Laboratories Limited | Process for the preparation of amorphous rosuvastatin calcium |
GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
WO2005077916A1 (en) | 2004-01-19 | 2005-08-25 | Ranbaxy Laboratories Limited | Salts of hmg-coa reductase inhibitors and use thereof |
TW200526596A (en) * | 2003-11-24 | 2005-08-16 | Teva Pharma | Crystalline ammonium salts of rosuvastatin |
HU227120B1 (hu) | 2005-05-26 | 2010-07-28 | Richter Gedeon Nyrt | Eljárás rosuvastatin kalciumsójának elõállítására új intermediereken keresztül |
PL1915349T5 (pl) * | 2005-06-24 | 2019-02-28 | Lek Pharmaceuticals D.D. | Sposób wytwarzania czystej bezpostaciowej rozuwastatyny wapniowej |
CA2612587C (en) | 2005-06-24 | 2013-02-19 | Lek Pharmaceuticals D.D. | Process for preparing amorphous rosuvastatin calcium free of impurities |
HU227696B1 (en) | 2006-04-13 | 2011-12-28 | Egyt Gyogyszervegyeszeti Gyar | Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it |
WO2007125547A2 (en) | 2006-05-03 | 2007-11-08 | Manne Satyanarayana Reddy | Novel process for statins and its pharmaceutically acceptable salts thereof |
EP2066644A2 (en) * | 2006-08-04 | 2009-06-10 | Glenmark Pharmaceuticals Limited | Salts of rosuvastatin and processes for their preparation |
HUE028475T2 (en) | 2006-10-09 | 2016-12-28 | Msn Laboratories Private Ltd | A novel process for the preparation of statins and their pharmaceutically acceptable salts |
US20080249120A1 (en) * | 2006-11-22 | 2008-10-09 | Glenmark Pharmaceuticals Limited | Pharmaceutical compositions |
WO2008067440A2 (en) | 2006-11-29 | 2008-06-05 | Dr. Reddy's Laboratories Ltd. | Rosuvastatin dehydroabietylamine salt |
CN102282136B (zh) * | 2009-01-14 | 2014-12-17 | 新梅斯托克尔卡·托瓦纳·兹德拉维尔公司 | 制备罗苏伐他汀的方法 |
-
2010
- 2010-01-15 WO PCT/HU2010/000007 patent/WO2010082072A1/en active Application Filing
- 2010-01-15 CA CA2749727A patent/CA2749727A1/en not_active Abandoned
- 2010-01-15 EP EP10707657A patent/EP2389365A1/en not_active Withdrawn
- 2010-01-15 CN CN2010800078203A patent/CN102317267A/zh active Pending
- 2010-01-15 AU AU2010205464A patent/AU2010205464A1/en not_active Abandoned
- 2010-01-15 MX MX2011007478A patent/MX2011007478A/es active IP Right Grant
- 2010-01-15 EA EA201190093A patent/EA021942B1/ru not_active IP Right Cessation
- 2010-01-15 BR BRPI1005147A patent/BRPI1005147A2/pt not_active IP Right Cessation
- 2010-01-15 US US13/143,943 patent/US8507513B2/en not_active Expired - Fee Related
-
2011
- 2011-07-12 ZA ZA2011/05124A patent/ZA201105124B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI1005147A2 (pt) | 2019-09-24 |
US8507513B2 (en) | 2013-08-13 |
EP2389365A1 (en) | 2011-11-30 |
EA021942B1 (ru) | 2015-10-30 |
WO2010082072A8 (en) | 2010-10-14 |
CA2749727A1 (en) | 2010-07-22 |
US20120116082A1 (en) | 2012-05-10 |
CN102317267A (zh) | 2012-01-11 |
ZA201105124B (en) | 2012-09-26 |
MX2011007478A (es) | 2011-09-15 |
AU2010205464A1 (en) | 2011-08-18 |
WO2010082072A1 (en) | 2010-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201190093A1 (ru) | Способ изготовления солей розувастатина | |
EA201370166A1 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
TWI341310B (en) | Improved production of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid calcium salt | |
MX2016002368A (es) | Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1). | |
CY1124329T1 (el) | N-(6-((2r,3s)-3,4-δiyδpoξyboytan-2-yλoξy)-2-(4-φθοροβενζυλοθειο)πυριμιδιν-4-υλ)-3-μεθυλαζετιδιν-1-σουλφοναμιδιο ως ρυθμιστης του υποδοχεα χημειοκινων | |
EA201700230A1 (ru) | Определенные аминопиридины, композиции на их основе и способы их применения | |
MY153057A (en) | Tryclic compounds,compositions and methods | |
PH12014502593A1 (en) | Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl]-1-methyl-urea and salts thereof | |
EA201190296A1 (ru) | Дисахариновая, дифумарово-кислая, ди-1-гидрокси-2-нафтойно-кислая и монобензойно-кислая соли 4-(диметиламино)бутил-2-(4-((2-амино-4-метил-6-(пентиламино)пиримидин-5-ил)метил)фенил)ацетата | |
IS2689B (is) | Kristallað form bis [(E)-7-[4-(4-flúorfenýl)-6-ísóprópýl-2-[metýl(metýlsúlfónýl) amínó]pýrimídin-5-ýl](3R, 5S)-3,5-díhýdroxýhept-6-ensýru] kalsíumsalts | |
EE200200445A (et) | 7-[4-(4-fluorofenüül)-6-isopropüül-2-metüül(metüülsulfonüül)amino]pürimidiin-5-üül] -(3R,5S)-3,5- dihüdroksühept-6-enohappe kristalsed soolad | |
EA201991779A3 (ru) | Способы получения ингибиторов jak киназ и родственных промежуточных соединений | |
WO2012017239A3 (en) | 4-(1h-indol-3-yl) -pyrimidines as alk inhibitors | |
BR112012010186A2 (pt) | derivados de heteroarila contendo n como inibidores de quinase jak3. | |
MX354482B (es) | Proceso de elaboración para derivados de pirimidina. | |
EA201270778A1 (ru) | Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119 | |
MX336343B (es) | Composiciones y metodos para mejorar la compatibilidad de las sales herbicidas solubles en agua. | |
EA201890663A1 (ru) | Соли ингибитора киназы pim | |
EA201300997A1 (ru) | ПИРИДО[2,3-b]ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ И ИХ ТЕРАПЕВТИЧЕСКИЕ ПРИМЕНЕНИЯ | |
EA201390771A1 (ru) | Способ получения фармацевтических промежуточных соединений высокой чистоты | |
TN2010000585A1 (en) | Pharmaceutical compositions of rosuvastatin calcium | |
EA201690818A1 (ru) | Замещенные пиримидиновые соединения и их применение в качестве syk ингибиторов | |
NZ611072A (en) | Method for preparing rosuvastatin salts | |
EA201170273A1 (ru) | Твердая фармацевтическая композиция | |
ATE553098T1 (de) | Verfahren zur herstellung von rosuvastatin- calcium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |